1. Home
  2. CHEK vs OBLG Comparison

CHEK vs OBLG Comparison

Compare CHEK & OBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • OBLG
  • Stock Information
  • Founded
  • CHEK 2004
  • OBLG 2000
  • Country
  • CHEK Israel
  • OBLG United States
  • Employees
  • CHEK N/A
  • OBLG N/A
  • Industry
  • CHEK Medical Electronics
  • OBLG Computer Software: Programming Data Processing
  • Sector
  • CHEK Health Care
  • OBLG Technology
  • Exchange
  • CHEK Nasdaq
  • OBLG Nasdaq
  • Market Cap
  • CHEK 4.3M
  • OBLG 4.5M
  • IPO Year
  • CHEK 2015
  • OBLG N/A
  • Fundamental
  • Price
  • CHEK $0.77
  • OBLG $3.12
  • Analyst Decision
  • CHEK
  • OBLG
  • Analyst Count
  • CHEK 0
  • OBLG 0
  • Target Price
  • CHEK N/A
  • OBLG N/A
  • AVG Volume (30 Days)
  • CHEK 19.6K
  • OBLG 207.1K
  • Earning Date
  • CHEK 08-14-2025
  • OBLG 08-06-2025
  • Dividend Yield
  • CHEK N/A
  • OBLG N/A
  • EPS Growth
  • CHEK N/A
  • OBLG N/A
  • EPS
  • CHEK N/A
  • OBLG N/A
  • Revenue
  • CHEK N/A
  • OBLG $2,374,000.00
  • Revenue This Year
  • CHEK N/A
  • OBLG N/A
  • Revenue Next Year
  • CHEK N/A
  • OBLG N/A
  • P/E Ratio
  • CHEK N/A
  • OBLG N/A
  • Revenue Growth
  • CHEK N/A
  • OBLG N/A
  • 52 Week Low
  • CHEK $0.56
  • OBLG $1.91
  • 52 Week High
  • CHEK $3.04
  • OBLG $8.40
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 45.27
  • OBLG 44.15
  • Support Level
  • CHEK $0.71
  • OBLG $3.30
  • Resistance Level
  • CHEK $0.77
  • OBLG $4.13
  • Average True Range (ATR)
  • CHEK 0.03
  • OBLG 0.50
  • MACD
  • CHEK -0.00
  • OBLG -0.10
  • Stochastic Oscillator
  • CHEK 46.23
  • OBLG 18.23

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About OBLG Oblong Inc.

Oblong Inc is a provider of patented multi-stream collaboration products and managed services for network solutions and video collaboration. The company's flagship product Mezzanine is the technology platform that defines computing: simultaneous multi-user, multi-screen, multi-device, and multi-location for dynamic and immersive visual collaboration. Mezzanine transforms routine meetings and workflows into agile, engaging experiences by making data visible and accessible in a collaborative setting. The mezzanine enables multiple, concurrent pieces of content to be shared, manipulated, created, and captured across distance. It serves various industries including aerospace, consulting, executive search, broadcast media, technology, financial services, education, healthcare, and real estate.

Share on Social Networks: